Stereotactic Body Radiation Therapy (SBRT) trials for Breast cancer

All Stereotactic Body Radiation Therapy (SBRT) trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Stereotactic Body Radiation Therapy (SBRT) for Breast cancer

• Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
  NCT05582499 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
  NCT06914440 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
  NCT06055881 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 2 locations
• Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.
  NCT06705127 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Stereotactic Body Radiation Therapy (SBRT) for Breast cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.